With Xi'an Lippon Enterprise Investment Co., Ltd. as its parent company, Lippon Enterprise has seven wholly-owned and holding subsidiaries, including Xi'an Lippon Pharmaceutical Co. The total number of employees is nearly one thousand.
As a high-tech enterprise, Lippon has a high-level and high-quality scientific research team consisting of doctors and masters as the backbone. Based on the R&D centers in China and Canada, Lippon also cooperates closely with a number of domestic and foreign pharmaceutical research institutes, and actively carries out the relevant R&D activities, and is currently the national demonstration engineering base for the industrialization of liposomes and the Shaanxi Provincial Liposome Engineering Technology Center, with its expertise in the fields of liposomes, fat emulsions, microemulsions, and drug-carrying microspheres. In 1999, Lippon was the first to successfully develop Propofol injection, which was awarded the "Queen's Award" in China and is still the closest to the ideal anesthesia preparation, "Limonixin". -Lemonixin has been ranked first in the domestic propofol market for many years, and its share in domestic hospitals has exceeded 40%.
The three pharmaceutical production bases of Lippon cover a total area of nearly 60,000 square meters, and have built many production lines for small-volume injections, large-volume injections, lyophilized powder injections, oral liquids, solid preparations, and related raw materials, etc., which are all GMP certified and partially FDA-certified, with more than 100 varieties of products, forming three major product series: anaesthesia, nutritional preparations, and cardio-cerebral and cerebral vascular preparations. There are more than 100 varieties, forming three major product series such as anesthesia drugs, nutritional preparations and cardiovascular drugs.
Libang is committed to building a core competitiveness of good efficacy, good quality, good service "three good" fine products, the formation of the decision-making, promotion and implementation of the marketing services of the "three systems", the marketing network covers 31 provinces, 6000 The marketing network covers 31 provinces and 6,000 medical institutions nationwide, laying a solid foundation for Lippon's brand building and sustainable development.
In 1999, Xi'an Lippon Clinical Nutrition Co., Ltd. was established as the first R&D and manufacturing enterprise of clinical enteral nutrition products in China, and developed a series of clinical nutrition products, which mainly include Lixikang enteral nutrition series products, maternal nutrition products, and maternal nutrition products. The company has developed a series of clinical nutrition products, mainly including "Lixikang" enteral nutrition series products, maternal nutrition products, and sports nutrition series products such as whey protein powder, glutamine, muscle powder, branched-chain amino acids, etc., which are specially developed for bodybuilders, aiming to meet the differentiated needs of different groups for nutrition products.
Xi'an Lipang Art & Culture Investment Co., Ltd. focuses on the management of cultural relics such as porcelain, paintings, jade, bronzes and miscellaneous items returned from abroad, as well as contemporary paintings and calligraphy and medium- and high-end original and replica works of art, which is the largest comprehensive cultural industry group in Xi'an Hi-tech Zone at present.
Entering the new period, facing the new opportunities and challenges, Lipang people adhering to the corporate mission of "advocating science, health of all living beings", carrying forward the spirit of "self-improvement, teamwork", and taking the direction of specialization, standardization, scaling and internationalization, pioneering, innovation, inspiring and striving for excellence. In the direction of specialization, standardization, scaling up and internationalization, we will continue to innovate and strive to make new leaps and bounds, and strive to write new glories, and make new and greater contributions to the cause of human health
/